Wednesday, 24 February 2016
ERJ Editor's choice
The February issue of the European Respiratory Journal (ERJ) features a study that considers the safety and efficacy of bedaquilline in a patient population treated for drug-resistant tuberculosis, including extensively drug-resistant TB. Visit erj.ersjournals.com to read this study and much more.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment